ACTIVATE: A Computerized Training Program for Children With ADHD

ADHD Clinical Trial

Official title:

ACTIVATE: A Computerized Training Program for Children With ADHD

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02562469
• Other study ID #: ACTIVATE
• Status: Completed
• Phase: N/A
• Start date: September 2015
• Est. completion date: August 2017

Study information

• Verified date: September 2018
• Source: New York University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

A preliminary clinical trial of ACTIVATE will be conducted in a sample of children with ADHD. ACTIVATE is a computerized neurocognitive training program (ACTIVATE; see: www.c8sciences.com) that simultaneously targets eight core neurocognitive factors (i.e., sustained attention, working memory (WM), response inhibition, speed of information processing, cognitive flexibility and control, multiple simultaneous attention, category formation, and pattern recognition and inductive thinking).

Description:

In an open clinical trial, ACTIVATE, a computer-based neurocognitive intervention will be evaluated to determine its effectiveness in improving symptoms of attention-deficit/hyperactivity disorder (ADHD) and related impairments. ACTIVATE is a computerized neurocognitive training program (ACTIVATE; see: www.c8sciences.com) that simultaneously targets eight core neurocognitive factors (i.e., sustained attention, working memory (WM), response inhibition, speed of information processing, cognitive flexibility and control, multiple simultaneous attention, category formation, and pattern recognition and inductive thinking). Youth between the ages of 7-11 will be recruited and assessed for ADHD and assigned to the ACTIVATE intervention. Assessment of outcomes will occur before, weekly during treatment, and immediately post-treatment.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 20
• Est. completion date: August 2017
• Est. primary completion date: August 2017
• Accepts healthy volunteers: No
• Gender: All
• Age group: 7 Years to 11 Years

Eligibility

Inclusion Criteria:

• Children ages 7-11 with a diagnosis of ADHD
• Parent and child must be fluent English speakers
• Family has access to desktop/laptop computer at home with internet access (in order to implement the ACTIVATE intervention component, which is an online-based computer program)

Exclusion Criteria:

• Developmental delay or psychosis that impacts the child's ability to function and engage in the computerized intervention
• If the youth or parent presents with emergency psychiatric needs that require services beyond that which can be managed within a preventive intervention format (e.g. hospitalization, specialized placement outside the home)
• If the child has an estimated Full Scale IQ below 80, based on completing two subtests of the Wechsler Intelligence Scale for Children - Fourth Edition

Related Conditions & MeSH terms

• ADHD

Intervention

Other:
• ACTIVATE
A home-based computerized brain training intervention for youth.

Locations

Country	Name	City	State
United States	New York University	New York	New York

Sponsors (1)

Lead Sponsor	Collaborator
New York University

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	ADHD symptoms on the Disruptive Behavior Rating Scale	Change in ADHD symptoms over the course of treatment	Change in ADHD symptoms at postreatment, which is expected to occur betwen 12-18 weeks from start of treatment

External Links

•   Families and Children Experiencing Success (FACES) Lab